Funding for Cancer Research Trainees

How are we doing? Send us your suggestions! Please let us know how we can improve this page, the newsletter, or anything else related to funding opportunity dissemination. 

Rolling Deadlines

Rolling: Siteman Trainee Travel Award

Additional Details

RFP Snapshot: The Siteman Trainee Travel Award supports scholars in career development related to cancer research or cancer health disparities research by providing reimbursement (i.e. registration, airfare, hotel, etc.) to present research at conferences and/or attend workshops/trainings. Scholars who are Underrepresented in Medicine (URiM) and/or women are strongly encouraged to apply.

Eligibility: Trainee must be affiliated with Siteman Cancer Center, Washington University, BJC, Children’s Hospital, SLU, or University of Missouri. All cancer related research and cancer disparities research trainees encouraged to apply. Priority given to NCI affiliated trainees. Must be a pre-doctoral trainee (doctoral student), postdoctoral trainee, research fellow, or early career faculty (instructor or assistant professor who has not yet held an R01 award). Conference location must be within the domestic USA; includes Canada, Mexico, and US Territories. This award may be used as a supplement to other scholarships, but may not be used to duplicate other resources.

Rolling Due Dates

Rolling: AACR Scholar-in-Training Awards: Other Conferences and Meetings

Additional Details

RFP Snapshot: The AACR offers Scholar-in-Training Awards to enhance the education and training of early career scientists by providing financial support for their attendance at AACR conferences and meetings. The number of awards available, award amounts, and application requirements vary by conference. Please visit the meetings and workshops calendar for a list of upcoming programs and details on financial support available.

Eligibility: Applicants who submit abstracts must be AACR members in good standing. Nonmembers should submit a Membership Application Form.

Rolling Due Dates

June Deadlines

June 28: MMRF Research Fellow Award - Multiple Myeloma Research Foundation

Additional Details

RFP Snapshot: The Research Fellowship Program is an initiative supporting early career researchers at the post-doctorate, medical fellow, or junior faculty levels currently active or interested in research in multiple myeloma. The goal of this initiative is to engage and support early career investigators interested in basic and clinical research focused on multiple myeloma and its precursor conditions, with the goal of advancing our understanding of myeloma disease biology, disease risk, and treatment response and relapse.

Max Amount and Period: $150,000 over 2 years

Eligibility: The MMRF Fellowship program is targeted to early career scientists. Applicants must have obtained their highest degree within 10 years of the application date. Post-doctorate and medical fellows applying for the award must work under the supervision of a research mentor in the multiple myeloma field. Applicants may not hold a position higher than Assistant Professor. Applicants who are beginning studies in the multiple myeloma field must have a research sponsor/mentor at their institution who is active in the multiple myeloma field, and who can provide guidance to the applicant in the proposed area of research. MMRF strongly encourages Black, Indigenous, and People of Color (BIPOC) scientists and clinicians interested in multiple myeloma research to apply.

Due Date: June 28, 2024

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

June 30: LOI: 2024 AAMDSIF Research Grant - Aplastic Anemia and MDS International Foundation

Additional Details

RFP Snapshot: These research grants will support investigators dedicated to studying bone marrow failure and advancing the understanding, prevention and treatment of bone marrow disorders in both pediatric and adult populations. In 2024, the AAMDSIF Research Grant Program will accept proposals in the following categories:
• Aplastic Anemia (focus on acquired)
• Myelodysplastic Syndromes/Neoplasms (MDS)
o MDS transition to Acute Myeloid Leukemia (AML)
• Paroxysmal Nocturnal Hemoglobinuria (PNH)
• Inherited bone marrow failure syndromes
In addition, proposals addressing the prevention or treatment of graft-vs-host disease (GVHD) related to hematopoietic
stem cell transplantation for bone marrow failure disease will be accepted in the 2024 grant cycle.

Max Amount and Period: $60,000 over 2 years

Eligibility: Eligible applicants will hold a MD, PhD, DO, D.Sc, or PharmD degree. Preference will be given to New Investigators who propose a project that will contribute toward their professional development in bone marrow failure disease research. New Investigators are post-doctoral fellows, Instructors, and those who have been Assistant Professors for fewer than five (5) years.

Due Date: Letter of Intent Due: June 30, 2024 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

June 30: Siteman Trainee Travel Awards - Siteman Cancer Center

Additional Details

RFP Snapshot: The Siteman Trainee Travel Award supports scholars in career development related to cancer research or cancer health disparities research by providing reimbursement (i.e. registration, airfare, hotel, etc.) to present research at conferences and/or attend workshops/trainings. Scholars who are Underrepresented in Medicine (URiM) and/or women are strongly encouraged to apply.

Max Amount and Period: $1,500 in travel funds

Eligibility: Trainee must be affiliated with Siteman Cancer Center, Washington University, BJC, Children’s Hospital, SLU, or University of Missouri. All cancer related research and cancer disparities research trainees encouraged to apply. Priority given to NCI affiliated trainees. Must be a pre-doctoral trainee (doctoral student), postdoctoral trainee, research fellow, or early career faculty (instructor or assistant professor who has not yet held an R01 award). Conference location must be within the domestic USA; includes Canada, Mexico, and US Territories. This award may be used as a supplement to other scholarships, but may not be used to duplicate other resources.

Due Date: June 30, 2024 at 10:59PM CST

July Deadlines

July 1: Childhood Cancer Research Grants - Pablove Foundation Seed Grants

Additional Details

RFP Snapshot: The Pablove Foundation invests in underfunded, cutting-edge pediatric cancer research and improves the lives of children living with cancer through the arts. Our mission is built on our impassioned desire to know more, find better, less toxic treatments, and a cure, and allow kids living with cancer to still be kids while undergoing treatment. Preferences going toward less common childhood cancers.

Max Amount and Period: $50,000 for 1 year

Eligibility: All the Powered by Pablove Seed Grants are designed for researchers currently towards the end of their clinical fellowship or postdoctoral training or within five (5) years of completion of training. Applicants must have an MD or PhD or equivalent degree. International applicants and institutions are welcome to apply for all grants; there is no residency requirement. Past Powered by Pablove grant recipients are not eligible to apply. Multiple LOI submissions for the same principal investigator, even if for different grant opportunities, are not allowed. Multiple applications are permitted from a single institution.

Due Date: July 1, 2024

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

July 1: Opsoclonus Myoclonus Syndrome (OMS) Grants - Pablove Foundation Seed Grants

Additional Details

RFP Snapshot: The Pablove Foundation invests in underfunded, cutting-edge pediatric cancer research and improves the lives of children living with cancer through the arts. Our mission is built on our impassioned desire to know more, find better, less toxic treatments, and a cure, and allow kids living with cancer to still be kids while undergoing treatment. Preferences going toward less common childhood cancers. This special interest opportunity welcomes broad ranging applications applicable to OMS, including from investigators who are in a clinical fellowship, postdoctoral training, or are
established investigators.

Max Amount and Period: $100,000 over 2 years

Eligibility: All the Powered by Pablove Seed Grants are designed for researchers currently towards the end of their clinical fellowship or postdoctoral training or within five (5) years of completion of training. Applicants must have an MD or PhD or equivalent degree. International applicants and institutions are welcome to apply for all grants; there is no residency requirement. Past Powered by Pablove grant recipients are not eligible to apply. Multiple LOI submissions for the same principal investigator, even if for different grant opportunities, are not allowed. Multiple applications are permitted from a single institution.

Due Date: July 1, 2024

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

July 10: WUSTL INTERNAL SELECTION: Career Transition Awards - Susan G. Komen

Washington University is eligible to nominate up to TWO candidates for this category, if at least one of the two nominees identifies as someone from groups shown to be historically minoritized and marginalized in biomedical research from National Science Foundation data, including Blacks or African Americans, Hispanics or Latinos, American Indians or Alaska Natives, Native Hawaiians and other Pacific Islanders, and individuals with disabilities, as well as individuals from disadvantaged backgrounds according to the criteria used by the NIH (https://extramural-diversity.nih.gov/diversity-matters/get-the-facts).

Additional Details

RFP Snapshot: This grant aims to help outstanding senior postdoctoral fellows and clinical fellows, working under the guidance of a mentor, launch their competitive, independent breast cancer research careers. Career Transition Awards provide up to five years of funding in two phases: Phase 1 supports the final years of mentored, postdoctoral training; and Phase 2 supports the independent research of the early career, tenure-track investigators. By supporting the most promising scientists and clinician-scientists as they embark on independent careers dedicated to breast cancer research, Komen seeks to ensure that a diverse group of highly trained scientists, who reflect the communities we serve, will emerge as the next generation of leaders in breast cancer research.

Max Amount and Period: $650,000 over 5 years

Eligibility: Applicants must be in the final years of mentored postdoctoral research training positions with no more than five years of total postdoctoral research experience at the time of Letter of Intent submission (August 7, 2024). For this application clinical fellows are considered eligible and equal to the postdoctoral rank. Applicants must have a doctoral degree, including MD, PhD, DrPH, DO, or equivalent. Applicants may not hold any appointment designated as faculty. Clinical fellows with the title of Instructor are allowed as long as they are no more than 5 years into their training similar to above bullet concerning postdoctoral training. Applicants must be able to devote at least 75% of full-time effort to breast cancer research and activities, i.e., protected research time. Applicant/PI may not hold another career transition award, training award (K-type awards) or R-type award at time of notification of intent to fund (on or around April 15, 2025). If Applicant previously held an R-type award at any point, they are not eligible to apply for this award. Applicants are not required to be a U.S. citizen or permanent resident.

WUSTL Internal Selection Documents Due: July 10, 2024 at 11:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

July 15: ACHIEVE Global Research Training Program - NIH Fogarty Global Health Fellowship / WUSTL ICHAD

Additional Details

RFP Snapshot: ACHIEVE is a one-year training appointment for trainees interested in applying dissemination and implementation (D&I) and data science methodologies in global health, with a special interest in projects related to children, adolescents, and their caregiving families; parenting; HIV/AIDS; mental health; cancer; nutrition; and environmental health. Questions may be directed to Chelsea Hand-Sheridan at [email protected].

Max Amount and Period: $10,000 in research project seed funding

Eligibility: Applicants must have completed a terminal degree (PhD, MD, MBChB, DrPH, etc.) within the past 6 years and have an interest in global health research. Applicants must be a US Citizen/LPR OR a Citizen of Ghana, Kenya, Rwanda, Sierra Leone, South Africa, or Uganda. Applicants must be willing to commit to work for 12 months in a global research site (trainees from Sub Saharan Africa must spend 1-3 months in the US).

Due Date: July 15, 2024

July 18: AACR-AstraZeneca Endometrial Cancer Research Fellowship

Additional Details

RFP Snapshot: This fellowship award represents a joint effort to encourage and support postdoctoral or clinical research fellows to conduct endometrial cancer research and to establish a successful career path in this field. The research proposed for funding must have direct applicability to endometrial cancer and may involve basic, translational, clinical, or population sciences research.

Max Amount and Period: $130,000 over 2 years

Eligibility: At the start of the grant term on November 1, 2024, applicants must hold a mentored research position with the title of postdoctoral fellow, clinical research fellow, or equivalent and must have completed their most recent doctoral degree within the past five years (conferred on November 1, 2019 or later).

Due Date: July 18, 2024 at Noon CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

August Deadlines

August 12: UICC Technical Fellowships - Union for International Cancer Control (UICC)

Additional Details

RFP Snapshot: The objective of the fellowship awards is to provide cancer professionals the chance to gain new knowledge, skills and techniques in cancer control through short learning visits of two weeks to two months’ duration.

Max Amount and Period: $2,200 over 2 weeks TO $5,800 over 8 weeks

Eligibility: Applicants may be of any nationality and may reside in any country at the time of application but must apply to visit a different country for their fellowship visit. Applicants must hold a minimum of a Master’s degree, while qualified medical doctors may be considered in the absence of a higher degree (i.e an MD) if they hold or are within a year of holding a board certification (or equivalent) in a cancer-related specialty, and registered nurses who have an RN qualification are also eligible to apply. An equivalent one-year’s training qualification in a specialty related to cancer post university degree can be accepted as an equivalent to a Master’s degree, for example training as a cancer registrar. All candidates should have worked in the field of cancer for at least five years prior to applying. Medical and PhD Students are not eligible to apply.

Due Date: August 12, 2024

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

August 13: WUSTL INTERNAL SELECTION: NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00)

Additional Details

RFP Snapshot: The F99/K00 award is intended for individuals who require 1-2 years to complete their PhD dissertation research training (F99 phase) before transitioning to mentored postdoctoral research training (K00 phase). Applicants should propose plans for individualized research training and 3-4 years of mentored postdoctoral research and career development activities.

Max Amount and Period: Up to 6 years combined support for both phases

Eligibility: The applicant must have a baccalaureate degree and be currently enrolled as a graduate student in the 3rd or 4th year of a mentored PhD (or equivalent) research degree program in the biomedical, behavioral, or clinical sciences. The applicant must be at the dissertation research stage of training at the time of award.

WUSTL INTERNAL SELECTION: WUSTL is invited to nominate ONE candidate.

Internal Due Date: August 13, 2024 at 11:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

August 15: AACR-AstraZeneca Breast Cancer Reserch Fellowship for Endocrine Therapy Research

Additional Details

RFP Snapshot: The AACR-AstraZeneca Breast Cancer Fellowship for Endocrine Therapy Research represent a joint effort to encourage and support postdoctoral or clinical research fellows to conduct breast cancer research and to establish a successful career path in this field. Proposed research projects are restricted to basic, clinical, translational or epidemiological projects that substantially advance the field of endocrine therapy in breast cancer.

Max Amount and Period: $130,000 over 2 years

Eligibility: Applicants must have a doctoral degree (including PhD, MD, MD/PhD, or equivalent) in a related field and not currently be a candidate for a further doctoral degree. At the start of the grant term on December 1, 2024, applicants must:
• Hold a mentored research position with the title of postdoctoral fellow, clinical research fellow, or the equivalent
• Have completed their most recent doctoral degree within the past five years (i.e., degree cannot have been conferred before December 1, 2019 the formal date of receipt of doctoral degree is the date the degree was conferred as indicated on your diploma and/or transcript)
• Work under the auspices of a mentor at an academic, medical, or research institution anywhere in the world.

Due Date: August 15, 2024 at Noon CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

August 15: Damon Runyon-St. Jude Pediatric Cancer Research Fellowship Award

Additional Details

RFP Snapshot: The goal is to fund individuals who propose innovative approaches in either basic or clinical research with the potential to significantly impact the prevention, diagnosis, or treatment of one or more pediatric cancers. Candidates must apply for the Damon Runyon-St. Jude Pediatric Cancer Research Fellowship under the guidance of a Sponsor, a scientist (tenured, tenure-track, or equivalent position) capable of providing mentorship to the Fellow.

Max Amount and Period: $300,000 over 4 years

Eligibility: Applicants must be MD, PhD, MD/PhD, DDS, DVM, Do, or equivalent. Candidates who have already accepted a postdoctoral research fellowship award are not eligible. Candidates may hold a T32 at the time of application, but not concurrently with the Damon Runyon-St. Jude Pediatric Cancer Research Fellowship Award.

• Level 1 Applicants: Basic and physician-scientists must have received their degrees no more than 18 montths prior to the application deadline and been in their sponsor’s lab for more than one year prior to the deadline. Applicants are expected to devote 100% of their time to Damon Runyon-supported research.

• Lever 2 Applicants: Physician-scientist applicants (MD, MD/PhD, DDS, DVM, DO or the equivalent) must have completed their residencies and clinical training, must be board eligible in the United States at the start date of the award, and be able to devote at least 80% of their time to Damon Runyon-supported research activities. Applicants may apply at any time prior to their initial assistant professorship appointment (or equivalent); postdoctoral fellows, clinical fellows, and clinical instructors are eligible to apply. Candidates holding or awarded NIH K awards at the time of application are not eligible to apply. Candidates holding institutional K12 awards may apply but must turn-back K12 funding if they are awarded a Damon Runyon-St. Jude Pediatric Cancer Research Fellowship Award.

Due Date: August 15, 2024 at 3PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

August 15: Damon Runyon Fellowship Award

Additional Details

RFP Snapshot: The Foundation encourages all theoretical and experimental research relevant to the study of cancer and the search for cancer causes, mechanisms, therapies and prevention. Candidates must apply for the fellowship under the guidance of a Sponsor—a scientist (tenured, tenure-track or equivalent position) capable of providing mentorship to the Fellow. In addition to aiding in the planning, execution and supervision of the proposed research, the Sponsor’s role is to foster the development of the Fellow’s overall knowledge, technical and analytical skills, and capacity for scientific inquiry. The Sponsor is also expected to assist the Fellow in attaining their career goals. Awards are made to institutions for the support of the Fellow under direct supervision of the Sponsor.

Max Amount and Period: $300,000 over 4 years

Eligibility: Applicants must be MD, PhD, MD/PhD, DDS, DVM, Do, or equivalent. Candidates who have already accepted a postdoctoral research fellowship award are not eligible. Candidates may hold a T32 at the time of application, but not concurrently with the Damon Runyon-St. Jude Pediatric Cancer Research Fellowship Award.

• Level 1 Applicants: Basic and physician-scientists must have received their degrees no more than 18 montths prior to the application deadline and been in their sponsor’s lab for more than one year prior to the deadline. Applicants are expected to devote 100% of their time to Damon Runyon-supported research.

• Lever 2 Applicants: Physician-scientist applicants (MD, MD/PhD, DDS, DVM, DO or the equivalent) must have completed their residencies and clinical training, must be board eligible in the United States at the start date of the award, and be able to devote at least 80% of their time to Damon Runyon-supported research activities. Applicants may apply at any time prior to their initial assistant professorship appointment (or equivalent); postdoctoral fellows, clinical fellows, and clinical instructors are eligible to apply. Candidates holding or awarded NIH K awards at the time of application are not eligible to apply. Candidates holding institutional K12 awards may apply but must turn-back K12 funding if they are awarded a Damon Runyon-St. Jude Pediatric Cancer Research Fellowship Award.

Due Date: August 15, 2024 at 3PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

August 26: Brian D. Novis Junior Research Grant - International Myeloma Foundation

Additional Details

RFP Snapshot: Brian D. Novis Research Awards go to researchers doing work in the field of multiple myeloma and related disorders including smoldering myeloma, MGUS (monoclonal gammopathy of undetermined significance) as well as immunoglobulin derived amyloidosis.

Max Amount and Period: $50,000 for 1 year

Eligibility: Applicants must have completed postdoc studies or clinical fellowships no later than October 1 of the application year and must be able to devote a minimum of 50% of their time to the research project.

Due Date: August 26, 2024 at 7PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

September Deadlines

September 1: CRI Irvington Postdoctoral Fellowship - Cancer Research Institute

Additional Details

RFP Snapshot: This opportunity supports qualified young scientists from underrepresented minorities at leading universities and research centers around the world who wish to receive training in fundamental immunology and cancer immunology. Fellows train under the guidance of a world-renowned immunologist, who sponsors the fellow and prepares him or her for a productive and successful career in cancer immunology. The program will provide additional support for mentoring and career advancement to these individuals, as we work to build a more racially diverse and inclusive community of scientists working in immuno-oncology.

Max Amount and Period: $243,000 over 3 years

Eligibility: This opportunity is open to candidates working in areas directly related to cancer immunology who identify as Black or African American, Hispanic or Latino, American Indian or Alaska Native, Native Hawaiian, or other Pacific Islander. CRI also recognizes that underrepresentation can vary from setting to setting; individuals from socioeconomically disadvantaged populations and from other racial or ethnic groups that can be demonstrated convincingly to be underrepresented by the grantee institution are encouraged to apply. Both U.S. and non-U.S. citizens are eligible. Applicants must have their doctoral degree by the date of award activation and have LESS THAN 5 years of postdoctoral experience, with the exception of MD applicants, who should not include years of residency. See RFA for more details.

Due Date: September 1, 2024 at 4PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

September 5: Lymphoma Postdoctoral Fellowship Grants - Lymphoma Research Foundation

Additional Details

RFP Snapshot: The Postdoctoral Fellowship Grant is designed to support investigators at the level of advanced fellow or postdoctoral researcher in laboratory or clinic- based research with results and conclusions that must be clearly relevant to the treatment, diagnosis or prevention of Hodgkin and/or non-Hodgkin lymphoma, including chronic lymphocytic leukemia. Areas of research may include, but are not limited to, etiology, immunology, genetics, therapies and 1 transplantation. Historically, successful applications in this program have focused on basic, translational, and epidemiological research.

Max Amount and Period: $195,000 over 2 years

Eligibility: Applicants must hold an MD, PhD, or equivalent degree. MD applicants must have completed at least two years (24 months) of their fellowship work at the start of the award period. All applicants should not have completed more than six years (72 months) of their fellowship or postdoctoral work at the start of their award period (March 1, 2025 or the start date indicated in their application budget). During the award period, the Grantee must spend a minimum of 80 percent of his/her time in research without major patient care, teaching, or administrative responsibilities except as such responsibilities relate directly to a pre-clinical or clinical lymphoma research project. Please see RFA for full eligibility requirements.

Due Date: September 5, 2024 at 4PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

September 12: AGA Fellowship-to-Faculty Transition Award - American Gastroenterological Association

Additional Details

RFP Snapshot: The objective of this AGA Research Foundation award is to provide funds to clinical and postdoctoral fellows to protect time dedicated to clinical or translational research to aid in their transition to independence. Projects must focus on the epidemiology, prevention, diagnosis, treatment or patient outcomes of a digestive disease or disorder.

Max Amount and Period: $130,000 for 1 year

Eligibility: Applicants for this award must hold an MD, PhD and/or equivalent degree (e.g., MBBS, MBChB, DO) and hold a clinical or postdoctoral fellow position. Clinical fellows must be in the final year of fellowship training or those in the year following the end of their fellowship training at the time of application. Postdoctoral fellows must have at least 4 years and fewer than 6 years of postdoctoral research at the time of application and be actively preparing to seek faculty positions before this award concludes. Postdoctoral applicants must clearly describe their plan for establishing scientific independence from their current mentor(s) and plans – including timeline – for applying to faculty positions. Applicants who have existing commitments for permanent faculty positions prior to the start date of the award are ineligible. AGA membership is required at the time of application submission. Applicants must have a mentor who is an AGA member at the time of application. Applicants performing exclusively basic research are ineligible.

Due Date: September 12, 2024

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

This newsletter is not fully inclusive of all available cancer-related funding for trainees.

Please be sure to consult other sources to learn of other opportunities not listed above.